Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains

por van der Vossen, Anna, Buljaç, Sandra, Akçay, Kadir, Brugma, Jan Dietert, Vulto, Arnold, Hanff, Lidwien
Publicado 2021

Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices

por Dane, Aniek, Klein Gebbink, Anne-Sophie, Brugma, Jan-Dietert, Degrassat-Théas, Albane, Hug, Martin J., Houlind, Morten B., Paubel, P., van der Kuy, P. Hugo M., Uyl-de Groot, Carin A.
Publicado 2023

Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands

por van der Groef, Romy, de Jong, Pascal H P, Hijnen, Dirk Jan, van der Woude, Christien J, van Laar, Jan A M, van der Kuy, P Hugo M, Brugma, Jan-Dietert, Pasma, Annelieke
Publicado 2023

Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry

por Looijen, Agnes E M, van Linschoten, Reinier C A, Brugma, Jan-Dietert, Hijnen, Dirk Jan, de Jong, Pascal H P, van der Kuy, P Hugo M, van Laar, Jan A M, van der Woude, C Janneke, Pasma, Annelieke
Publicado 2023